Operating income increased 19.1%
Operating income changed +19.1% from the comparable as-filed period.
$6.8M→$8.1M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →IRMD financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capex / revenue moved 483 bp lower
Capex / revenue changed -483 basis points from the comparable as-filed period.
5.37%→0.54%2 prior comparisons
Revenue increased 14.2%
Revenue changed +14.2% from the comparable as-filed period.
$21.2M→$24.2M2 prior comparisons
Operating margin moved 140 bp higher
Operating margin changed +140 basis points from the comparable as-filed period.
32.23%→33.63%2 prior comparisons
Gross margin moved 154 bp lower
Gross margin changed -154 basis points from the comparable as-filed period.
77.80%→76.26%2 prior comparisons
Current liabilities decreased 19.3%
Current liabilities changed -19.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$12.8M→$10.3M3 prior comparisons
Free-cash-flow proxy increased 17.4%
Free-cash-flow proxy changed +17.4% from the comparable as-filed period.
$5.8M→$6.9M2 prior comparisons
Capital expenditure decreased 88.6%
Capital expenditure changed -88.6% from the comparable as-filed period.
$1.1M→$130,0002 prior comparisons
Research & development increased 29.8%
Research & development changed +29.8% from the comparable as-filed period.
$674,362→$875,0002 prior comparisons
Working capital / assets moved 526 bp higher
Working capital / assets changed +526 basis points from the comparable as-filed period.
62.87%→68.12%3 prior comparisons
Operating cash-flow margin moved 404 bp lower
Operating cash-flow margin changed -404 basis points from the comparable as-filed period.
32.95%→28.91%2 prior comparisons
Current ratio increased 35.5%
Current ratio changed +35.5% from the comparable as-filed period.
6.64→8.993 prior comparisons
Cost of revenue increased 22.1%
Cost of revenue changed +22.1% from the comparable as-filed period.
$4.7M→$5.7M2 prior comparisons
Working capital increased 14.4%
Working capital changed +14.4% from the comparable as-filed period.
$72.1M→$82.5M3 prior comparisons
Cash & equivalents increased 12.0%
Cash & equivalents changed +12.0% from the comparable as-filed period.
$56.5M→$63.3M3 prior comparisons
Receivables / revenue moved 887 bp lower
Receivables / revenue changed -887 basis points from the comparable as-filed period.
65.36%→56.50%2 prior comparisons
Inventory increased 14.9%
Inventory changed +14.9% from the comparable as-filed period.
$11.7M→$13.5M3 prior comparisons
Current assets increased 9.3%
Current assets changed +9.3% from the comparable as-filed period.
$84.9M→$92.8M3 prior comparisons
Gross profit increased 11.9%
Gross profit changed +11.9% from the comparable as-filed period.
$16.5M→$18.5M2 prior comparisons
Total assets increased 5.5%
Total assets changed +5.5% from the comparable as-filed period.
$114.7M→$121.1M3 prior comparisons
Stock-based compensation increased 16.7%
Stock-based compensation changed +16.7% from the comparable as-filed period.
$666,083→$777,0002 prior comparisons
Inventory / revenue moved 38 bp higher
Inventory / revenue changed +38 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
55.35%→55.72%2 prior comparisons
Shares outstanding increased 0.5%
Shares outstanding changed +0.5% from the comparable as-filed period. The change ranks at the 57th percentile of 7 prior comparable changes.
12,721,156→12,788,1537 prior comparisons
Operating cash flow increased 0.2%
Operating cash flow changed +0.2% from the comparable as-filed period.
$7.0M→$7.0M2 prior comparisons
SBC / revenue moved 7 bp higher
SBC / revenue changed +7 basis points from the comparable as-filed period.
3.14%→3.21%2 prior comparisons
R&D / revenue moved 43 bp higher
R&D / revenue changed +43 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
3.18%→3.62%2 prior comparisons
Trade receivables decreased 1.3%
Trade receivables changed -1.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$13.9M→$13.7M3 prior comparisons
Free-cash-flow margin moved 79 bp higher
Free-cash-flow margin changed +79 basis points from the comparable as-filed period.
27.58%→28.37%2 prior comparisons
Gross margin moved 410 bp lower
Gross margin changed -410 basis points from the comparable as-filed period.
78.17%→74.07%2 prior comparisons
Inventory / revenue moved 501 bp higher
Inventory / revenue changed +501 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
54.88%→59.89%2 prior comparisons
Capex / revenue moved 1201 bp lower
Capex / revenue changed -1201 basis points from the comparable as-filed period.
12.91%→0.90%2 prior comparisons
Capital expenditure decreased 93.0%
Capital expenditure changed -93.0% from the comparable as-filed period.
$2.6M→$185,0003 prior comparisons
Operating cash flow decreased 23.3%
Operating cash flow changed -23.3% from the comparable as-filed period.
$7.7M→$5.9M3 prior comparisons
Operating margin moved 203 bp lower
Operating margin changed -203 basis points from the comparable as-filed period.
33.26%→31.23%2 prior comparisons
Working capital / assets moved 305 bp higher
Working capital / assets changed +305 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
64.41%→67.46%3 prior comparisons
Trade receivables increased 20.8%
Trade receivables changed +20.8% from the comparable as-filed period.
$10.9M→$13.2M3 prior comparisons
Free-cash-flow proxy increased 12.6%
Free-cash-flow proxy changed +12.6% from the comparable as-filed period.
$5.1M→$5.8M3 prior comparisons
Operating income decreased 5.8%
Operating income changed -5.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$6.8M→$6.4M2 prior comparisons
Research & development decreased 25.1%
Research & development changed -25.1% from the comparable as-filed period.
$877,362→$657,0002 prior comparisons
Operating cash-flow margin moved 893 bp lower
Operating cash-flow margin changed -893 basis points from the comparable as-filed period.
37.95%→29.02%2 prior comparisons
Receivables / revenue moved 1094 bp higher
Receivables / revenue changed +1094 basis points from the comparable as-filed period.
53.52%→64.46%2 prior comparisons
Working capital increased 13.1%
Working capital changed +13.1% from the comparable as-filed period.
$68.6M→$77.6M3 prior comparisons
Cash & equivalents increased 11.5%
Cash & equivalents changed +11.5% from the comparable as-filed period.
$53.0M→$59.1M3 prior comparisons
Free-cash-flow margin moved 308 bp higher
Free-cash-flow margin changed +308 basis points from the comparable as-filed period.
25.04%→28.12%2 prior comparisons
Current assets increased 12.1%
Current assets changed +12.1% from the comparable as-filed period.
$77.4M→$86.7M3 prior comparisons
Cost of revenue increased 19.1%
Cost of revenue changed +19.1% from the comparable as-filed period.
$4.5M→$5.3M2 prior comparisons
Revenue increased 0.3%
Revenue changed +0.3% from the comparable as-filed period.
$20.4M→$20.5M2 prior comparisons
Total assets increased 8.0%
Total assets changed +8.0% from the comparable as-filed period.
$106.4M→$115.0M3 prior comparisons
Inventory increased 9.4%
Inventory changed +9.4% from the comparable as-filed period.
$11.2M→$12.3M3 prior comparisons
Shares outstanding increased 0.5%
Shares outstanding changed +0.5% from the comparable as-filed period. The change ranks at the 57th percentile of 7 prior comparable changes.
12,720,002→12,786,9917 prior comparisons
SBC / revenue moved 36 bp higher
SBC / revenue changed +36 basis points from the comparable as-filed period.
3.58%→3.94%2 prior comparisons
Gross profit decreased 5.0%
Gross profit changed -5.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$16.0M→$15.2M2 prior comparisons
R&D / revenue moved 109 bp lower
R&D / revenue changed -109 basis points from the comparable as-filed period.
4.30%→3.21%2 prior comparisons
Stock-based compensation increased 10.5%
Stock-based compensation changed +10.5% from the comparable as-filed period.
$730,618→$807,0002 prior comparisons
Current ratio increased 7.8%
Current ratio changed +7.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
8.78→9.463 prior comparisons
Current liabilities increased 4.0%
Current liabilities changed +4.0% from the comparable as-filed period.
$8.8M→$9.2M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.